Medications That Cause Depression in Elderly: A Drug-by-Drug Guide

The Problem Hiding in the Medicine Cabinet

A medication might be causing or worsening depression-like symptoms, so a clinician should assess both possibilities. About 80% of older adults manage at least one chronic medical condition, and half manage two or more. Several widely prescribed drug classes can contribute to depressive symptoms, and the risk compounds when multiple offenders are stacked together. Older adults experience adverse drug events at a rate of 50 per 1,000 person-years, with hospitalizations four to seven times more frequent than in younger populations.

Before assuming depression needs an antidepressant, a thorough medication review should be the first step.

The Major Offenders

Corticosteroids (Prednisone, Dexamethasone, Methylprednisolone). These can disrupt blood-brain barrier homeostasis and alter neurotransmitter pathways. Short-term use may cause euphoria or agitation; long-term systemic use is strongly linked to clinical depression and cognitive disturbances. Mood changes can appear as early as five days after starting treatment, and the risk is dose-dependent — higher doses mean higher risk.

Benzodiazepines (Lorazepam, Alprazolam, Diazepam) and Z-drugs (Zolpidem, Eszopiclone). Prescribed for anxiety and insomnia, these are central nervous system depressants that cause chronic sedation, emotional blunting, and cognitive slowing — all of which mimic or amplify depression. The AGS Beers Criteria recommends avoiding them entirely in older adults due to high correlation with cognitive impairment, delirium, physical dependence, and a near-doubling of fall and fracture risk.

Lipophilic beta-blockers (Metoprolol, Propranolol). These cross the blood-brain barrier and depress central adrenergic activity, causing daytime fatigue, disrupted sleep cycles, and low mood. Not all beta-blockers carry this risk equally — hydrophilic options like atenolol are less likely to affect the central nervous system.

Central alpha-agonists (Clonidine, Guanfacine). Used for hypertension, these carry high risks of orthostatic hypotension and adverse CNS effects, contributing directly to psychomotor retardation and depressive fatigue.

First-generation antihistamines (Diphenhydramine, Doxylamine, Hydroxyzine). The anticholinergic load from these over-the-counter drugs is significant: cognitive decline, confusion, sedation, and social withdrawal. Many older adults take diphenhydramine (Benadryl) nightly as a sleep aid without realizing the cumulative cognitive damage.

Proton pump inhibitors (Omeprazole, Lansoprazole). Long-term PPI use has been linked in large-scale studies to elevated risk of depression and suicidal ideation. The mechanism is still being studied, but clinical guidelines already suggest evaluating necessity of chronic PPI therapy in older adults with new-onset mood changes.

Anticonvulsants (Gabapentin, Valproate). These carry FDA warnings regarding mood changes and suicidal ideation, and they interfere with coordination and balance — increasing fall risk and further restricting an older adult's activity level.

How to Do a Medication Audit

Don't try to evaluate drug interactions on your own. Instead, prepare for the conversation:

1. List everything. Every prescription, over-the-counter drug, supplement, and topical medication. Include dosages and how long they've been taking each one.
2. Flag the Beers Criteria drugs. Ask the doctor: "Are any of these on the AGS Beers Criteria list?" This is a direct, non-confrontational question that signals you've done your homework.
3. Ask about depressogenic potential. "Could any of these medications be causing or worsening depressive symptoms?" Doctors are generally receptive to this question when it comes with a complete medication list rather than vague concerns.
4. Ask about prescribing cascades. This is when a side effect from Drug A gets treated with Drug B, whose side effect gets treated with Drug C. If a medication is unnecessary, ask the prescriber whether it can be deprescribed; do not stop or taper it independently.

The Timing Question

If your parent's mood deteriorated shortly after starting a new medication or having a dose increased, that timing is valuable diagnostic information. Document it: "Mom's mood started declining about two weeks after her cardiologist increased her metoprolol dose." Doctors make better decisions when caregivers provide timelines rather than general impressions.

The Spotting Elder Depression toolkit includes a structured medication audit worksheet cross-referenced to high-risk drug classes, plus clinical scripting templates for the doctor conversation — built for exactly this kind of systematic review.